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Editorial on the Research Topic
Antimicrobial Resistance and Virulence CommonMechanisms
Multiple relationships exist between antimicrobial resistance and bacterial virulence, and the spread
of clones combining multiple antibiotic resistance and a high virulence level is an increasing
problem. These relationships have been previously reviewed, notably by Beceiro et al. (2013),
who described how mutation-driven or horizontally acquired resistance mechanisms can also have
effects on virulence. It was also reported that mobile genetic elements often carry both resistance
determinants and virulence-modulating genes, which favors the co-selection of both traits. In
the present volume, we present a collection of articles which document additional aspects of the
interactions between antimicrobial resistance and virulence in bacteria, and describe their potential
therapeutic consequences.
In an excellent review article, Alcade-Rico et al. established that multidrug eﬄux pumps are
“at the cross-road between resistance and virulence of bacterial pathogens.” They describe how
multidrug eﬄux pumps are involved, besides antibiotic resistance, in many physiological and
virulence-related processes controlled by complex regulatory networks. A special focus is made
on the role of these eﬄux pumps in bacterial cell-to-cell communication and in bacterial-host
interactions.
Another example of link between resistance and virulence in Staphylococci is given in
a mini review by Qin et al. The authors summarized how the psm-mec locus present in
some methicillin-resistant Staphylococcus aureus (MRSA) and coagulase-negative Staphylococci
influences methicillin resistance and virulence-related phenotypes, including the ability to form
biofilms.
In another paper also dealing with biofilms, Wang et al. used an up-to-date iTRAQ protein
labeling technology to identify proteins that are differencially expressed in Streptococcus suis treated
with sub-MIC concentrations of tylosin. These concentrations were indeed capable of inhibition
of biofilm formation by this zoonotic pathogen, which is of interest, since biofilms are known to
display an increased tolerance to antibiotics.
This antibiotic tolerance of bacteria present in biofilms is thought to be at least partially due to
the presence of higher numbers of persisters than in planktonic bacterial populations. Persisters
are phenotypic variants of bacteria which are able to survive antibiotic treatments in a dormancy
state and to resume growth when the (antibiotic) stress is withdrawn. Like antibiotic-resistant
bacteria, antibiotic-tolerant persisters are also often responsible for failures of antibiotic therapies.
However, the mechanisms underlying their production are still not well-understood. An article by
Xu et al. lifts a corner of the veil on this subject in Staphylococcus aureus by suggesting that heme
biosynthesis, in addition to being necessary to a full expression of virulence, is also important in
the formation of persisters in S. aureus.
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Another study by Chen et al. addressed the problem of
antibiotic tolerance in extraintestinal pathogenic Escherichia coli
(ExPEC). Authors studied the role of polyphosphate kinase
(PPK), an enzyme already known for its implication in motility,
quorum sensing or virulence, in antibiotic tolerance. Their results
indicate that PPK is important for the antibiotic stress response
and may therefore be a valuable antibacterial target, especially
since it is absent in mammals.
Small Colony Variants (SCV) represent another state in which
bacteria are more tolerant to antibiotics. The clinical importance
of SCV has been well-documented in cases of chronic infections
by S. aureus and Pseudomonas aeruginosa but their existence was
only recently reported in Listeria monocytogenes, a food pathogen
producing recurrent infections despite being rarely resistant to
antibiotics. In an original research article, Curtis et al. described
a heme mutant displaying a SCV phenotype mutant with an
increased tolerance toward most of the relevant antibiotics. They
suggest that the SCV phenotype of L. monocytogenes should be
screened in clinical laboratories, as it might be associated to
complicated antibiotic treatments.
Genetic changes leading to antimicrobial resistance are
expected to result in higher fitness costs in the absence of
antibiotic selection pressure. On the other hand, increased
resistance is sometimes associated with increased virulence or to
a better adaptation to stress conditions. This topic is developed
in a study by Schaufler et al. who reported that the carriage of
extended spectrum beta-lactamase (ESBL)-plasmids by strains
of pandemic E. coli lineages did not lead to a fitness cost.
Instead, these plasmids could enhance virulence or adaptation to
specific habitats by influencing the expression of chromosomal
genes.
In another article dealing with bacterial fitness, Agnello
et al. presented results that possibly explain why highly virulent
P. aeruginosa strains, which often possess the exoU toxin
gene, are more frequently resistant to fluoroquinolones than
the generally less virulent strains harboring the exoS toxin
gene. Their results support the hypothesis that fitness cost
imposed by fluoroquinolone resistance may be lower and
“more easily” compensable by exoU strains than by exoS
strains.
In a whole genome sequence-based study, Hao et al. analyze
a multidrug resistant and virulent Campylobacter jejuni strain
isolated from a broiler chicken. By comparison to reference
strains, they revealed that the phenotype of this isolate was
associated with large differences in the genome structure and
content. This study provides an example of how a stepwise
accumulation of mutations in antibiotic target genes, acquisition
of exogenous resistance genes and virulence associated genes
can result in the emergence of isolates that are both multidrug-
resistant and virulent.
Since quorum sensing is a major player in the control
of virulence factors in P. aeruginosa, therapies based on
quorum sensing interference (QSI) have been envisaged
as possible alternatives to conventional antibiotic therapies
against this pathogen. In a thoughtful perspective article,
Garcia-Contreras, however, compiles many recent experimental
evidence which actually indicate that early optimistic
expectations about QSI should be put in perspective.
Indeed, he estimates that a far better understanding of
P. aeruginosa virulence and behavior during infection is
needed before efficient QSI-based clinical applications can be
designed.
In addition to some immunomodulating activities,
azithromycin (AZM) has various inhibiting effects on
P. aeruginosa such as bacterial killing or the repression
of multiple virulence factors. This antibiotic is therefore
currently used in the treatment of cystic fibrosis patients,
whose lungs are commonly colonized by this pathogen.
However, P. aeruginosa responds to AZM by yet unknown
mechanisms and is able to counteract its killing and virulence-
inhibitory effects. An interesting work by Tan et al. revealed
that PA3297, a P. aeruginosa gene encoding a DEAH-box
helicase, is involved in this response. Indeed, deficiency of
this gene renders P. aeruginosa more susceptible to the killing
and to virulence suppression by AZM. Authors therefore
suggested that targeting the regulatory pathway of PA3297 or its
function might increase the beneficial effect of AZM in chronic
P. aeruginosa infections such as those occuring in cystic fibrosis
patients.
At last, in a pharmacological perspective, Obtreska-Machaj
et al. report the development of hydantoin derivatives that have
increased activity as inhibitors of the AcrAB-TolC eﬄux pump
of Enterobacter aerogenes. Close homologs of this multidrug
pump are also present in other pathogenic enterobacteria and
involved in their virulence. The authors defined important
pharmacophoric groups whose modulation may allow to develop
still more potent inhibitors capable of restoring antibiotic activity
in AcrAB producing bacteria.
It is likely that both resistant and virulent high risk clones
will continue to emerge and spread in the next years. Several
factors supports this hypothesis, among which the facts that
highly pathogenic bacterial strains are more likely to be subjected
to the selective pressure of antibiotics treatments, that virulence
and resistance determinants are sometimes genetically associated
and that fitness and virulence impairments that often accompany
acquisition of resistance can be compensated in the long term
by suppressor mutations (Beceiro et al., 2013; Mathers et al.,
2015). In spite of these facts, virulence and antimicrobial
resistance are studied usually separately rather than jointly.
But now, as exemplified in this research topic, time has come
for more integrative studies linking both traits and their co-
evolution, so that we may be better armed against future bacterial
threats.
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